Physician profile
John E Lapkass
NPI 1154363166
$2,017.93
in general payments reported to CMS, 2019-2025
21 companies · $51.56 in 2025
The $51.56 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $493 · 2021: $201 · 2022: $606 · 2023: $354 · 2024: $312 · 2025: $51.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $534 · Education: $183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.95 |
| Education | $183.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $748.41 | 2019-2023 | Persona |
| Stryker Corporation | $185.45 | 2019-2022 | |
| Acumed LLC | $183.38 | 2023-2025 | Acumed, Innate Implant, Acumed |
| Smith+Nephew, INC. | $169.04 | 2019-2024 | Pico, Bioinductive Implant With Arthroscopic Delivery System - Medium, Stravix |
| Kci USA, INC. | $149.25 | 2022 | |
| Solventum Corporation | $88.25 | 2024 | Prevena, V.A.C.Instill, V.A.C. Granufoam |
| Heron Therapeutics, INC. | $79.61 | 2019-2022 | |
| Bioventus LLC | $61.01 | 2019-2022 | |
| Abbott Laboratories | $56.27 | 2022 | |
| Becton, Dickinson and Company | $42.61 | 2021-2024 | Arista Ah Flexitip |
| Depuy Synthes Sales INC. | $40.08 | 2019-2024 | Monovisc |
| My01 INC. | $33.20 | 2025 | My01 Continuous Compartmental Pressure Monitor |
| Organogenesis INC. | $29.13 | 2023 | Puraply |
| Avanos Medical | $28.88 | 2023 | On-Q* Pump and Accessories |
| Radius Health, INC. | $22.81 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $21.21 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $20.55 | 2024 | Exparel |
| Convatec INC. | $20.13 | 2019 | |
| Ferring Pharmaceuticals INC. | $16.24 | 2019 | |
| Pacira Therapeutics, INC. | $11.70 | 2019 | |
| Si-Bone, INC. | $10.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lapkass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.